Table 3 ACE I/D, Ang II AT2 receptor C3123A, and AGT M235T genotype distributions in CAD and healthy patients
From: Renin–angiotensin system gene polymorphisms among Saudi patients with coronary artery disease
Genotype | Groups | p value | ||
|---|---|---|---|---|
Control | CAD patients | Total | ||
(n = 110) | (n = 225) | (n = 335) | ||
ACE I/D | ||||
DD | 62 (56.4%) | 145 (64.4%) | 207 (61.79%) | 0.023 |
ID | 26 (23.6%) | 59 (26.3%) | 85 (25.37%) | |
II | 22 (20.0%) | 21 (9.3%) | 43(12.84%) | |
Ang II AT2 (C3123A) | ||||
CC | 43 (39.1%) | 89 (39.6%) | 132 (39.40%) | 0.0001 |
CA | 67 (60.9%) | 40 (17.8%) | 107 (31.94%) | |
AA | 0 | 96 (42.6%) | 96 (28.66%) | |
AGT (M235T) | ||||
MM | 29 (26.40%) | 54 (24.0%) | 83 (24.78%) | 0.102 |
MT | 50 (45.50%) | 98 (43.6%) | 148 (44.18%) | |
TT | 31 (28.20%) | 73 (32.4%) | 104 (31.04%) | |